Glucose-regulated Glucagon Secretion Requires Insulin Receptor Expression in Pancreatic α-Cells*

The insulin receptor (IR) and its signaling appear to be essential for insulin secretion from pancreatic β-cells. However, much less is known about the role of the IR in α-cells. To assess the role of the IR in glucagon and insulin secretion, we engineered adeno-viruses for high efficiency small interference RNA (siRNA)-IR expression in isolated mouse pancreatic islets and lentiviruses for siRNA-IR expression in pancreatic α- and β-cell lines (α-TC6 and MIN6) with specific, long term stable IR knockdown. Western blot analysis showed that these strategies resulted in 60-80% reduction of IR protein in islets and α- and β-cell lines. Cell growth was reduced by 35-50% in α-TC and MIN6 cells stably expressing siRNA-IR, respectively. Importantly, glucagon secretion, in response to glucose (25 to 2.8 mm), was completely abolished in islets expressing siRNA-IR, whereas secretion increased 1.7-fold in islets expressing control siRNA. In contrast, there was no difference in glucose-stimulated insulin secretion when comparing siRNA-IR and siRNA control, with both groups showing a 1.7-fold increase. Islet glucagon and insulin content were also unaffected by IR knockdown. To further explore the role of the IR, siRNA-IR was stably expressed in pancreatic cell lines, which dramatically suppressed glucose-regulated glucagon secretion in α-TC6 cells (3.4-fold) but did not affect GSIS in MIN6 cells. Defects in siRNA-IR-expressing α-cells were associated with an alteration in the activity of Akt and p70S6K where insulin-induced phosphorylation of protein kinase B/AKt was greatly reduced while p70S6K activation was enhanced, suggesting that the related pathways play important roles in α cell function. This study provides direct evidence that appropriate expression of the IR in α-cells is required for glucose-dependent glucagon secretion.

[1]  M. Ravier,et al.  Glucose or Insulin, but not Zinc Ions, Inhibit Glucagon Secretion From Mouse Pancreatic α-Cells , 2005 .

[2]  P. Cryer,et al.  Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin-deficient diabetes: documentation of the intraislet insulin hypothesis in humans. , 2005, Diabetes.

[3]  James D. Johnson,et al.  Reduced Expression of the Insulin Receptor in Mouse Insulinoma (MIN6) Cells Reveals Multiple Roles of Insulin Signaling in Gene Expression, Proliferation, Insulin Content, and Secretion* , 2005, Journal of Biological Chemistry.

[4]  J. Carvalheira,et al.  Regulation of insulin signalling by hyperinsulinaemia: role of IRS-1/2 serine phosphorylation and the mTOR/p70 S6K pathway , 2005, Diabetologia.

[5]  M. White,et al.  Signaling Pathways: The Benefits of Good Communication , 2004, Current Biology.

[6]  Catherine B. Chan,et al.  Free Fatty Acid-induced β-Cell Defects Are Dependent on Uncoupling Protein 2 Expression* , 2004, Journal of Biological Chemistry.

[7]  Xiaosong Ma,et al.  ATP-Sensitive K+ Channel–Dependent Regulation of Glucagon Release and Electrical Activity by Glucose in Wild-Type and SUR1−/− Mouse α-Cells , 2004 .

[8]  A. Poeppl,et al.  Bioluminescent imaging of a marking transgene and correction of Fabry mice by neonatal injection of recombinant lentiviral vectors. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[9]  S Del Prato,et al.  Beta- and Alpha-Cell Dysfunction in Type 2 Diabetes , 2004, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[10]  N. Kobayashi,et al.  Adenovirus Mediated Gene Transduction of Primarily Isolated Mouse Islets , 2004, ASAIO journal.

[11]  T. Hunter,et al.  Inappropriate Activation of the TSC/Rheb/mTOR/S6K Cassette Induces IRS1/2 Depletion, Insulin Resistance, and Cell Survival Deficiencies , 2004, Current Biology.

[12]  Johan Auwerx,et al.  Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity , 2004, Nature.

[13]  C. Newgard,et al.  An adenovirus vector for efficient RNA interference-mediated suppression of target genes in insulinoma cells and pancreatic islets of langerhans. , 2004, Diabetes.

[14]  J. Agudo,et al.  In vivo gene transfer to pancreatic beta cells by systemic delivery of adenoviral vectors. , 2004, Human gene therapy.

[15]  I. Gout,et al.  The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins , 2004, The Journal of cell biology.

[16]  L. Gawenis,et al.  A domain mimic increases DeltaF508 CFTR trafficking and restores cAMP-stimulated anion secretion in cystic fibrosis epithelia. , 2004, American journal of physiology. Cell physiology.

[17]  R. DePinho,et al.  The LKB1 tumor suppressor negatively regulates mTOR signaling. , 2004, Cancer cell.

[18]  R. Robertson,et al.  Regulation of α-Cell Function by the β-Cell in Isolated Human and Rat Islets Deprived of Glucose: the “Switch-off” Hypothesis , 2004 .

[19]  R. Robertson,et al.  Regulation of α-Cell Function by the β-Cell During Hypoglycemia in Wistar Rats: the “Switch-off” Hypothesis , 2004 .

[20]  K. Yoshimoto,et al.  Differentiation phenotypes of pancreatic islet β- and α-cells are closely related with homeotic genes and a group of differentially expressed genes , 2004 .

[21]  J. Blenis,et al.  Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression , 2004, Oncogene.

[22]  P. Rorsman,et al.  Glucose inhibition of glucagon secretion from rat alpha-cells is mediated by GABA released from neighboring beta-cells. , 2004, Diabetes.

[23]  F. Ashcroft,et al.  Type 2 diabetes mellitus: not quite exciting enough? , 2004, Human molecular genetics.

[24]  G. Rutter,et al.  Distinct roles for insulin and insulin-like growth factor-1 receptors in pancreatic beta-cell glucose sensing revealed by RNA silencing. , 2004, The Biochemical journal.

[25]  C. Kahn,et al.  Insulin receptor knockout mice. , 2003, Annual review of physiology.

[26]  S. Ryu,et al.  Phosphatidic Acid Regulates Systemic Inflammatory Responses by Modulating the Akt-Mammalian Target of Rapamycin-p70 S6 Kinase 1 Pathway* , 2003, Journal of Biological Chemistry.

[27]  Y. Moriyama,et al.  Vesicular Inhibitory Amino Acid Transporter Is Present in Glucagon-Containing Secretory Granules in αTC6 Cells, Mouse Clonal α-Cells, and α-Cells of Islets of Langerhans , 2003 .

[28]  S. Schreiber,et al.  Integration of growth factor and nutrient signaling: implications for cancer biology. , 2003, Molecular cell.

[29]  C. Wollheim,et al.  Islet β-cell secretion determines glucagon release from neighbouring α-cells , 2003, Nature Cell Biology.

[30]  M. White,et al.  c-Jun N-terminal Kinase (JNK) Mediates Feedback Inhibition of the Insulin Signaling Cascade* , 2003, The Journal of Biological Chemistry.

[31]  N. Kimura,et al.  A possible linkage between AMP‐activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway , 2003, Genes to cells : devoted to molecular & cellular mechanisms.

[32]  D. Accili,et al.  Mouse models of insulin resistance. , 2004, American journal of physiology. Endocrinology and metabolism.

[33]  Catherine B. Chan,et al.  Inhibition of Kv2.1 Voltage-dependent K+Channels in Pancreatic β-Cells Enhances Glucose-dependent Insulin Secretion* , 2002, The Journal of Biological Chemistry.

[34]  Michael Karin,et al.  A central role for JNK in obesity and insulin resistance , 2002, Nature.

[35]  D. Gilot,et al.  PI3K‐FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival , 2002, Hepatology.

[36]  G. Thomas,et al.  Lethality of Drosophila lacking TSC tumor suppressor function rescued by reducing dS6K signaling. , 2002, Genes & development.

[37]  Kirk W. Johnson,et al.  Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats. , 2002, Diabetes.

[38]  R. Bernards,et al.  A System for Stable Expression of Short Interfering RNAs in Mammalian Cells , 2002, Science.

[39]  B. Meyer,et al.  Haemochromatosis mutations and ferritin in myocardial infarction: a case‐control study , 2002, European journal of clinical investigation.

[40]  P. Cryer,et al.  Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. , 2002, Diabetes.

[41]  G. Thomas The S6 kinase signaling pathway in the control of development and growth. , 2002, Biological research.

[42]  Graeme I. Bell,et al.  Diabetes mellitus and genetically programmed defects in β-cell function , 2001, Nature.

[43]  A. Jaeschke,et al.  Mammalian TOR: A Homeostatic ATP Sensor , 2001, Science.

[44]  Hong Wu,et al.  Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[45]  R. Burcelin,et al.  Hypoinsulinaemia, glucose intolerance and diminished β-cell size in S6K1-deficient mice , 2000, Nature.

[46]  J W Yates,et al.  Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. , 2000, Chemistry & biology.

[47]  L. Terracciano,et al.  Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6. , 2000, Science.

[48]  Roger Davis,et al.  The c-Jun NH2-terminal Kinase Promotes Insulin Resistance during Association with Insulin Receptor Substrate-1 and Phosphorylation of Ser307 * , 2000, The Journal of Biological Chemistry.

[49]  H. Edlund,et al.  Pancreas: how to get there from the gut? , 1999, Current opinion in cell biology.

[50]  P. MacDonald,et al.  Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets. , 1999, Diabetes.

[51]  S. Gammeltoft,et al.  Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction , 1999, Molecular and Cellular Endocrinology.

[52]  P. Cohen,et al.  The Croonian Lecture 1998. Identification of a protein kinase cascade of major importance in insulin signal transduction. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[53]  B. Kemp,et al.  Dealing with energy demand: the AMP-activated protein kinase. , 1999, Trends in biochemical sciences.

[54]  H. Berman,et al.  Metabolic engineering with recombinant adenoviruses. , 1999, Annual review of nutrition.

[55]  M. Carlson,et al.  The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? , 1998, Annual review of biochemistry.

[56]  M. Kitamura,et al.  Construction of adenovirus vectors through Cre-lox recombination , 1997, Journal of virology.

[57]  P. Cohen,et al.  Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.

[58]  L. Dekker,et al.  Activation of PRK1 by Phosphatidylinositol 4,5-Bisphosphate and Phosphatidylinositol 3,4,5-Trisphosphate , 1995, The Journal of Biological Chemistry.

[59]  S. Kahn,et al.  The key role of islet dysfunction in type II diabetes mellitus. , 1995, Clinical and investigative medicine. Medecine clinique et experimentale.

[60]  B. Gabrielli,et al.  A cardiolipin-activated protein kinase from rat liver structurally distinct from the protein kinases C. , 1994, The Journal of biological chemistry.

[61]  D. Hanahan,et al.  Precursor cells of mouse endocrine pancreas coexpress insulin, glucagon and the neuronal proteins tyrosine hydroxylase and neuropeptide Y, but not pancreatic polypeptide. , 1993, Development.

[62]  W. Tamborlane,et al.  Loss of Potentiating Effect of Hypoglycemia on the Glucagon Response to Hyperaminoacidemia in IDDM , 1993, Diabetes.

[63]  D. Drucker,et al.  Alterations in proglucagon processing and inhibition of proglucagon gene expression in transgenic mice which contain a chimeric proglucagon-SV40 T antigen gene. , 1992, The Journal of biological chemistry.

[64]  C. Greenbaum,et al.  Intra-islet insulin permits glucose to directly suppress pancreatic A cell function. , 1991, The Journal of clinical investigation.

[65]  K. Hamaguchi,et al.  Comparison of Cytokine Effects on Mouse Pancreatic α-Cell and β-Cell Lines Viability, Secretory Function, and MHC Antigen Expression , 1990, Diabetes.

[66]  P. Rorsman,et al.  Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channels , 1989, Nature.

[67]  V. Marks,et al.  The order of islet microvascular cellular perfusion is B----A----D in the perfused rat pancreas. , 1988, The Journal of clinical investigation.

[68]  L. Orci,et al.  Insulin within islets is a physiologic glucagon release inhibitor. , 1984, The Journal of clinical investigation.

[69]  P. Brunetti,et al.  Abnormal Glucose Counterregulation in Insulin-dependent Diabetes Mellitus: Interaction of Anti-Insulin Antibodies and Impaired Glucagon and Epinephrine Secretion , 1983, Diabetes.

[70]  S. Friesen Tumors of the endocrine pancreas. , 1982, The New England journal of medicine.

[71]  J. Palmer,et al.  In vivo inhibition of glucagon secretion by paracrine beta cell activity in man. , 1981, The Journal of clinical investigation.

[72]  R. Rizza,et al.  Hormonal mechanisms in acute glucose counterregulation: the relative roles of glucagon, epinephrine, norepinephrine, growth hormone, and cortisol. , 1980, Metabolism: clinical and experimental.

[73]  L Orci,et al.  Endocrine pancreas: three-dimensional reconstruction shows two types of islets of langerhans. , 1979, Science.

[74]  P. Raskin,et al.  Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics. , 1975, The Journal of clinical investigation.

[75]  J. Gerich,et al.  Lack of Glucagon Response to Hypoglycemia in Diabetes: Evidence for an Intrinsic Pancreatic Alpha Cell Defect , 1973, Science.